BACKGROUND There exists scant evidence on the optimal approaches to integrating patient-reported outcomes (PROs) in clinical practice. This study gathered oncology practitioners' experiences with implementing PROs in cancer care. METHODS Between December 2019 and June 2020, we surveyed practitioners who reported spending > 5% of their time providing clinical care to cancer patients. Respondents completed an online survey describing their experiences with and barriers to using PROs in clinical settings. RESULTS In total, 362 practitioners (physicians 38.7%, nurses 46.7%, allied health professionals 14.6%) completed the survey, representing 41 countries (Asia-Pacific 42.5%, North America 30.1%, Europe 24.0%, others 3.3%). One quarter (25.4%) identified themselves as "high frequency users" who conducted PRO assessments on > 80% of their patients. Practitioners commonly used PROs to facilitate communication (60.2%) and monitor treatment responses (52.6%). The most commonly reported implementation barriers were a lack of technological support (70.4%) and absence of a robust workflow to integrate PROs in clinical care (61.5%). Compared to practitioners from high-income countries, more practitioners in low-middle income countries reported not having access to a local PRO expert (P < .0001) and difficulty in identifying the appropriate PRO domains (P = .006). Compared with nurses and allied health professionals, physicians were more likely to perceive disruptions in clinical care during PRO collection (P = .001) as an implementation barrier. CONCLUSIONS Only a quarter of the surveyed practitioners reported capturing PROs in routine clinical practice. The implementation barriers to PRO use varied across respondents in different professions and levels of socioeconomic resources. Our findings can be applied to guide planning and implementation of PRO collection in cancer care.

中文翻译：

---

在常规癌症护理中使用患者报告的结果：来自对肿瘤学从业者的跨国范围调查的初步见解。

背景在临床实践中整合患者报告结果 (PROs) 的最佳方法的证据很少。本研究收集了肿瘤从业者在癌症护理中实施 PRO 的经验。方法 在 2019 年 12 月至 2020 年 6 月期间，我们调查了报告花费超过 5% 的时间为癌症患者提供临床护理的从业者。受访者完成了一项在线调查，描述了他们在临床环境中使用 PRO 的经历和障碍。结果 共有 362 名从业人员（医师 38.7%，护士 46.7%，专职医疗人员 14.6%）完成了调查，代表 41 个国家（亚太地区 42.5%，北美 30.1%，欧洲 24.0%，其他 3.3%）。四分之一 (25.4%) 将自己定义为“高频用户”，他们对 > 80%的患者。从业者通常使用 PRO 来促进沟通（60.2%）和监测治疗反应（52.6%）。最常报告的实施障碍是缺乏技术支持（70.4%）和缺乏将 PRO 整合到临床护理中的强大工作流程（61.5%）。与来自高收入国家的从业者相比，更多中低收入国家的从业者报告称无法联系当地的 PRO 专家 (P < .0001) 并且难以确定适当的 PRO 领域 (P = .006)。与护士和专职医疗人员相比，医生更有可能将 PRO 收集期间的临床护理中断 (P = .001) 视为实施障碍。结论 只有四分之一的接受调查的从业者报告说在常规临床实践中捕获了 PRO。PRO 使用的实施障碍因不同专业和社会经济资源水平的受访者而异。我们的研究结果可用于指导癌症护理中 PRO 收集的规划和实施。